Financial Ratios Guangdong Highsun Meida New Materials Co., Ltd.
Stocks
000782
CNE0000002K7
Commodity Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.440 CNY | -0.53% |
|
-0.13% | +50.00% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.97 | -1.14 | -1.83 | -1.03 | -1.87 | |||||
Return on Total Capital | 3.02 | -1.72 | -2.64 | -1.51 | -2.73 | |||||
Return On Equity % | 3.85 | -3.8 | -10.65 | -4.63 | -9.03 | |||||
Return on Common Equity | 3.85 | -3.8 | -10.65 | -4.63 | -9.03 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 8.85 | 3.19 | 1.74 | 2.61 | 1.44 | |||||
SG&A Margin | 4.83 | 4.74 | 4.84 | 3.79 | 4.41 | |||||
EBITDA Margin % | 5.44 | 0.58 | -0.94 | 0.73 | -0.8 | |||||
EBITA Margin % | 2.87 | -1.93 | -3.27 | -1.4 | -3.58 | |||||
EBIT Margin % | 2.84 | -1.97 | -3.41 | -1.61 | -3.8 | |||||
Income From Continuing Operations Margin % | 1.69 | -1.89 | -5.06 | -2.16 | -6.24 | |||||
Net Income Margin % | 1.69 | -1.89 | -5.06 | -2.16 | -6.24 | |||||
Net Avail. For Common Margin % | 1.69 | -1.89 | -5.06 | -2.16 | -6.24 | |||||
Normalized Net Income Margin | 1.37 | -1.07 | -2.33 | -0.92 | -2.22 | |||||
Levered Free Cash Flow Margin | 6.86 | -2.13 | -2.12 | -3.31 | -24.47 | |||||
Unlevered Free Cash Flow Margin | 7.27 | -1.63 | -1.53 | -3.04 | -24.37 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.11 | 0.92 | 0.86 | 1.03 | 0.79 | |||||
Fixed Assets Turnover | 4.68 | 4.37 | 4.27 | 5.12 | 3.01 | |||||
Receivables Turnover (Average Receivables) | 4.43 | 4.1 | 4.63 | 5.39 | 4.6 | |||||
Inventory Turnover (Average Inventory) | 7.41 | 6.38 | 6.37 | 7.89 | 6.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.27 | 1.13 | 1.02 | 1.66 | 1.21 | |||||
Quick Ratio | 0.9 | 0.79 | 0.78 | 1.17 | 0.81 | |||||
Operating Cash Flow to Current Liabilities | 0.02 | -0.23 | -0.2 | -0.35 | -0 | |||||
Days Sales Outstanding (Average Receivables) | 82.36 | 89.01 | 78.83 | 67.86 | 79.43 | |||||
Days Outstanding Inventory (Average Inventory) | 49.26 | 57.24 | 57.32 | 46.36 | 53.97 | |||||
Average Days Payable Outstanding | 88.98 | 102.41 | 102.32 | 92.11 | 118.73 | |||||
Cash Conversion Cycle (Average Days) | 42.64 | 43.83 | 33.82 | 22.11 | 14.67 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 31.17 | 57.14 | 83.68 | 12.62 | 39.79 | |||||
Total Debt / Total Capital | 23.76 | 36.36 | 45.56 | 11.2 | 28.46 | |||||
LT Debt/Equity | 8.28 | - | 2.38 | 3.83 | 32.67 | |||||
Long-Term Debt / Total Capital | 6.31 | - | 1.3 | 3.4 | 23.37 | |||||
Total Liabilities / Total Assets | 52.89 | 54.91 | 62.91 | 39.18 | 51.04 | |||||
EBIT / Interest Expense | 4.35 | -2.45 | -3.57 | -3.69 | -23.37 | |||||
EBITDA / Interest Expense | 8.34 | 0.73 | -0.98 | 1.67 | -4.94 | |||||
(EBITDA - Capex) / Interest Expense | 7.62 | -1.26 | -9.83 | -1.75 | -213.91 | |||||
Total Debt / EBITDA | 2.56 | 47.61 | -39.92 | 9.49 | -32.7 | |||||
Net Debt / EBITDA | 0.09 | 6.3 | -4.27 | -15.68 | -15.51 | |||||
Total Debt / (EBITDA - Capex) | 2.8 | -27.47 | -3.99 | -9.02 | -0.76 | |||||
Net Debt / (EBITDA - Capex) | 0.1 | -3.64 | -0.43 | 14.9 | -0.36 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 41.3 | -12.24 | -3.3 | 15.49 | -24.48 | |||||
Gross Profit, 1 Yr. Growth % | 97.95 | -68.35 | -47.14 | 72.54 | -58.45 | |||||
EBITDA, 1 Yr. Growth % | 89.28 | -90.57 | -255.03 | -189.39 | -183.63 | |||||
EBITA, 1 Yr. Growth % | 1.77K | -159.09 | 63.59 | -50.64 | 93.21 | |||||
EBIT, 1 Yr. Growth % | 2.32K | -161.07 | 66.96 | -45.62 | 78.83 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 53.89 | -198.12 | 158.44 | -50.77 | 118.42 | |||||
Net Income, 1 Yr. Growth % | 47.65 | -198.12 | 158.44 | -50.77 | 118.42 | |||||
Normalized Net Income, 1 Yr. Growth % | 201.39 | -168.38 | 110.38 | -54.11 | 81.28 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 57.14 | -190.91 | 170 | -62.96 | 120 | |||||
Accounts Receivable, 1 Yr. Growth % | 27.85 | -30.55 | 9.13 | -9.96 | -13.01 | |||||
Inventory, 1 Yr. Growth % | 15.09 | 2.4 | -5.72 | -9.73 | -11.95 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.66 | -1.97 | -0.26 | -7.02 | 66.41 | |||||
Total Assets, 1 Yr. Growth % | 11.73 | -0.18 | 7.9 | -14 | 13.45 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.33 | -4.61 | -24.81 | 50.64 | -9.4 | |||||
Common Equity, 1 Yr. Growth % | 3.15 | -4.44 | -11.25 | 41.02 | -8.67 | |||||
Cash From Operations, 1 Yr. Growth % | -110.32 | -1.59K | 8.25 | -11.75 | -99.67 | |||||
Capital Expenditures, 1 Yr. Growth % | 13.69 | 199.82 | 410.77 | -79.63 | 1.62K | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -225.73 | -127.55 | -3.46 | 84.04 | 457.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -245.59 | -119.62 | -9.06 | 129.92 | 504.89 | |||||
Dividend Per Share, 1 Yr. Growth % | 50 | 0 | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.44 | 11.35 | -7.88 | 5.67 | -6.61 | |||||
Gross Profit, 2 Yr. CAGR % | 53.61 | -20.85 | -59.1 | -4.5 | -15.02 | |||||
EBITDA, 2 Yr. CAGR % | 135.44 | -57.75 | -61.77 | 17.72 | -13.54 | |||||
EBITA, 2 Yr. CAGR % | 19.82 | 232.78 | -1.68 | -10.14 | -2.35 | |||||
EBIT, 2 Yr. CAGR % | 18.02 | 284.47 | 0.97 | -4.72 | -1.39 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 128 | 22.88 | 59.24 | 12.79 | 3.69 | |||||
Net Income, 2 Yr. CAGR % | 99.17 | 20.37 | 59.24 | 12.79 | 3.69 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.08 | 43.67 | 19.94 | -1.75 | -8.79 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 91.49 | 19.52 | 56.67 | 0 | -9.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 76.29 | -5.77 | -12.94 | -0.88 | -11.5 | |||||
Inventory, 2 Yr. CAGR % | 12.18 | 8.56 | -1.75 | -7.75 | -10.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -10.63 | -5.89 | -1.12 | -3.7 | 24.39 | |||||
Total Assets, 2 Yr. CAGR % | 8.81 | 5.61 | 3.78 | -3.67 | -1.22 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.31 | -0.72 | -15.31 | 6.43 | 16.82 | |||||
Common Equity, 2 Yr. CAGR % | 2.12 | -0.72 | -7.91 | 11.87 | 13.49 | |||||
Cash From Operations, 2 Yr. CAGR % | -62.45 | 24.06 | 301.85 | -2.26 | -94.62 | |||||
Capital Expenditures, 2 Yr. CAGR % | -33.55 | 84.63 | 291.33 | 2 | 87.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.45 | -41.5 | -48.43 | 31.88 | 220.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 8.56 | -46.56 | -57.76 | 44.6 | 272.93 | |||||
Dividend Per Share, 2 Yr. CAGR % | 22.47 | 22.47 | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.51 | -0.82 | 6.24 | -0.67 | -5.52 | |||||
Gross Profit, 3 Yr. CAGR % | 2.43 | -9.27 | -30.81 | -33.91 | -27.46 | |||||
EBITDA, 3 Yr. CAGR % | 0.34 | -19.45 | -34.84 | -49.26 | 5.04 | |||||
EBITA, 3 Yr. CAGR % | 8.34 | -5.32 | 162.64 | -21.86 | 15.98 | |||||
EBIT, 3 Yr. CAGR % | 8.55 | -5.24 | 191.14 | -17.85 | 17.53 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.77 | 72.14 | 57.44 | 7.67 | 40.59 | |||||
Net Income, 3 Yr. CAGR % | 14.69 | 57.31 | 55.28 | 7.67 | 40.59 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.47 | -11.9 | 63.15 | -12.93 | 20.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 16.26 | 49.38 | 56.83 | -3.13 | 30.06 | |||||
Accounts Receivable, 3 Yr. CAGR % | 26.3 | 29.23 | -1.05 | -11.96 | -5.1 | |||||
Inventory, 3 Yr. CAGR % | 4.33 | 8.82 | 3.57 | -4.48 | -9.17 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -8.94 | -7.83 | -4.05 | -3.13 | 15.56 | |||||
Total Assets, 3 Yr. CAGR % | 2.91 | 5.73 | 6.37 | -2.52 | 1.73 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.24 | -0.05 | -9.5 | 2.62 | 0.87 | |||||
Common Equity, 3 Yr. CAGR % | 1.1 | -0.12 | -4.36 | 6.15 | 4.56 | |||||
Cash From Operations, 3 Yr. CAGR % | -53.75 | 28.14 | 18.55 | 142.45 | -85.38 | |||||
Capital Expenditures, 3 Yr. CAGR % | -33.4 | 9.8 | 159.18 | 46.12 | 161.75 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 38.61 | -29.92 | -30.87 | -21.75 | 113.25 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.31 | -38.62 | -36.2 | -25.7 | 132.99 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.47 | 14.47 | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.53 | -3.92 | -5.87 | 1.73 | 0.9 | |||||
Gross Profit, 5 Yr. CAGR % | 12.33 | -19.31 | -29.05 | -7.39 | -24.88 | |||||
EBITDA, 5 Yr. CAGR % | 24.62 | -37.2 | -31.79 | -6.25 | -27.03 | |||||
EBITA, 5 Yr. CAGR % | 14.79 | -4.19 | 4.22 | -7.28 | 76.8 | |||||
EBIT, 5 Yr. CAGR % | 13.39 | -3.41 | 5.46 | -5.03 | 88.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -7.16 | 8.45 | 30.15 | 45.36 | 33.22 | |||||
Net Income, 5 Yr. CAGR % | -7.15 | 9.54 | 30.78 | 37.71 | 32.12 | |||||
Normalized Net Income, 5 Yr. CAGR % | -0.32 | 11.27 | 19.69 | -7.97 | 29.29 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -6.01 | 7.39 | 30.99 | 27.23 | 25.74 | |||||
Accounts Receivable, 5 Yr. CAGR % | 15.82 | -5.82 | 8.83 | 16.22 | -5.37 | |||||
Inventory, 5 Yr. CAGR % | 3.06 | 7.96 | 1.85 | 1.86 | -2.46 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -7.7 | -6.91 | -5.89 | -6.2 | 6.45 | |||||
Total Assets, 5 Yr. CAGR % | 4.39 | 1.42 | 3.26 | 1.86 | 3.26 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.02 | -0.05 | -5.73 | 2.49 | 0.23 | |||||
Common Equity, 5 Yr. CAGR % | 4.85 | -0.03 | -2.61 | 4.52 | 2.41 | |||||
Cash From Operations, 5 Yr. CAGR % | -41.49 | 7.55 | 9.82 | 14.98 | -65.6 | |||||
Capital Expenditures, 5 Yr. CAGR % | -18.21 | 2.9 | 35.24 | 6.61 | 127.64 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -7.07 | -28.91 | -6.89 | -9.75 | 27.12 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.96 | -31.94 | -17.35 | -13.53 | 29.29 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.45 | -5.59 | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
















